Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
European Journal of Internal Medicine|July 16, 2025
Senolytic therapies for cardiovascular aging: tackling fibrosis and metabolic dysfunctionSandra Atlante, Michela Gottardi Zamperla, Luca Cis, et al.
European Journal of Internal Medicine|February 12, 2026
Omics medicine: what the clinicians should knowMichela Gottardi Zamperla, Veronica Barbi, Sara Negri, et al.
Clinical Epigenetics|October 22, 2020
The epigenetic implication in coronavirus infection and therapySandra Atlante, Alessia Mongelli, Veronica Barbi, et al.
International Journal of Molecular Sciences|January 17, 2020
Epigenetic Signaling and RNA Regulation in Cardiovascular DiseasesAlessia Mongelli, Sandra Atlante, Tiziana Bachetti, et al.
Investigative Radiology|September 11, 2019
Gadolinium Retention in Erythrocytes and Leukocytes From Human and Murine Blood Upon Treatment With Gadolinium-Based Contrast Agents for Magnetic Resonance ImagingEnza Di Gregorio, Chiara Furlan, Sandra Atlante, et al.
International Journal of Molecular Sciences|October 30, 2020
Treating Senescence like Cancer: Novel Perspectives in Senotherapy of Chronic DiseasesAlessia Mongelli, Sandra Atlante, Veronica Barbi, et al.
Expert Opinion on Therapeutic Targets|May 22, 2026
Emergent RNA targets in cardiovascular disease: likely candidates for treatment developmentVeronica Barbi, Maria Anele Romeo, Michela Gottardi Zamperla, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|August 7, 2021
Analysis of the Gadolinium retention in the Experimental Autoimmune Encephalomyelitis (EAE) murine model of Multiple SclerosisChiara Furlan, Francesca Montarolo, Enza Di Gregorio, et al.
Geroscience|November 4, 2024
The COVID-19 legacy: consequences for the human DNA methylome and therapeutic perspectivesCarlo Gaetano, Sandra Atlante, Michela Gottardi Zamperla, et al.
European Journal of Medicinal Chemistry|January 1, 2018
Structural and biological characterization of new hybrid drugs joining an HDAC inhibitor to different NO-donorsSandra Atlante, Konstantin Chegaev, Chiara Cencioni, et al.
Pageof 3